re: News: Regeneus presents at the ASX Spotli...
I feel the same Massey,Regeneus are at the forefront of the adipose cell technology. Cell therapy will eventually hit like a tidal wave IMO as the word spreads about its success. Regeneus is generating profits with Hi Q,cryoshot ,Alogen A brands. They have their fingers in in many more trials. Cryoshot trials on humans coming.The trials on dog cancerous tumours in the USA results so far being outstanding. It is a high risk industry ,but i feel Regeneus are a much lower risk,than most.
RGS Price at posting:
47.0¢ Sentiment: LT Buy Disclosure: Held